Multiple Myeloma Baseline Immunoglobulin G Level and Pneumococcal Vaccination Antibody Response

Multiple Myeloma Baseline Immunoglobulin G Level and Pneumococcal Vaccination Antibody Response

Infections are a major cause of morbidity and mortality in multiple myeloma (MM), a cancer of the immune system. Vaccination clinical efficacy endpoints have not been demonstrated, and there are limited data on surrogate markers of efficacy. This pilot study evaluated sequential immunologic markers...

Full description

Bibliographic Details
Main Authors: Michael A. Thompson, Martin K. Oaks, Maharaj Singh, Karen M. Michel, Michael P. Mullane, Husam S. Tarawneh, Angi Kraut, Kayla J. Hamm
Format: Article
Language:English
Published: Advocate Aurora Health 2017-08-01
Series:Journal of Patient-Centered Research and Reviews
Subjects:
multiple myeloma
vaccination
pneumococcal
clinical efficacy
immunology
antibody
immunoglobulin G
Online Access:http://digitalrepository.aurorahealthcare.org/cgi/viewcontent.cgi?article=1453&context=jpcrr

Internet

http://digitalrepository.aurorahealthcare.org/cgi/viewcontent.cgi?article=1453&context=jpcrr

Similar Items